Bank Of America Corp Ac Immune Sa Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Ac Immune Sa stock. As of the latest transaction made, Bank Of America Corp holds 2,511 shares of ACIU stock, worth $4,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,511

Previous 2,888 13.05%

Holding current value

$4,268

Previous $7,000 42.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.87 - $2.98 $704 - $1,123	-377 Reduced 13.05%	2,511 $4,000
Q4 2024 Feb 14, 2025	SELL	$2.67 - $3.75 $2,912 - $4,091	-1,091 Reduced 27.42%	2,888 $7,000
Q3 2024 Nov 14, 2024	BUY	$2.99 - $4.2 $3,250 - $4,565	1,087 Added 37.59%	3,979 $15,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.87 $50 - $107	-22 Reduced 0.75%	2,892 $11,000
Q1 2024 May 15, 2024	BUY	$2.66 - $4.87 $7,064 - $12,934	2,656 Added 1029.46%	2,914 $8,000
Q4 2023 Feb 14, 2024	BUY	$2.46 - $5.0 $634 - $1,290	258 New	258 $1,000
Q4 2022 Feb 10, 2023	SELL	$1.72 - $3.12 $705 - $1,279	-410 Reduced 97.62%	10 $0
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $1,106 - $1,678	-461 Reduced 52.33%	420 $2,000
Q2 2022 Aug 12, 2022	SELL	$2.35 - $4.47 $6,751 - $12,842	-2,873 Reduced 76.53%	881 $3,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $3,566 - $5,258	1,019 Added 37.26%	3,754 $15,000
Q4 2021 Feb 08, 2022	SELL	$4.83 - $7.56 $34,500 - $54,001	-7,143 Reduced 72.31%	2,735 $13,000
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $34,912 - $46,962	5,631 Added 132.59%	9,878 $66,000
Q2 2021 Sep 13, 2021	BUY	$6.04 - $8.37 $25,651 - $35,547	4,247 New	4,247 $34,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.4M

Call Options Held

4.8K

Put Options Held

22.2K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $142M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Ac Immune Sa Transaction History